How do I ensure my genetic testing workflows with a qPCR system are compliant with IVD regulatory clearance?

To ensure qPCR-based genetic testing workflows are compliant with IVD regulatory clearance, focus on two layers:

1. The test system itself must be cleared/approved for the intended use.
2. Your laboratory workflow must use it exactly within that cleared intended use, with proper quality and validation controls.

Here’s a practical compliance checklist:

1) Confirm the intended use matches your workflow

Review the manufacturer’s labeling for:

• Analyte / genes / variants covered
• Specimen type allowed
• Population / setting intended use
• Instrument, reagents, software versions included
• Whether it is FDA-cleared, CE-IVD, or other region-specific IVD

If your workflow differs from the label in any material way, it may no longer be covered by the clearance.

2) Use only validated, cleared components

Make sure all critical components are:

• IVD-cleared/approved reagents and kits
• Compatible qPCR instrument
• Cleared analysis software
• Approved controls/calibrators

Avoid substituting:

• Non-cleared primers/probes
• Different extraction methods
• Alternative software or manual thresholding, unless the manufacturer’s instructions allow it

3) Follow the IFU exactly

Your SOPs should mirror the Instructions for Use (IFU):

• Sample collection, storage, and transport
• Extraction method
• PCR setup and cycling conditions
• Accept/reject criteria
• Interpretation algorithm
• Reporting language

Deviations from the IFU can push the test into a modified use case that requires additional validation.

4) Perform verification or validation as required

Even with a cleared IVD, your lab typically needs to verify performance in its own hands, including:

• Accuracy
• Precision/reproducibility
• Analytical sensitivity/specificity
• Reportable range / cutoff verification
• Interfering substances
• Specimen stability, if applicable

If you modify the assay or use it outside the intended use, you may need a more extensive validation rather than simple verification.

5) Implement quality management controls

Maintain:

• Documented SOPs
• Lot-to-lot verification
• Calibration and maintenance logs
• QC acceptance criteria
• Proficiency testing, if available/required
• Deviations and corrective/preventive action (CAPA)

6) Control software and data integrity

Ensure:

• Audit trails are enabled
• User access is controlled
• Electronic records comply with applicable requirements
• Data analysis is locked to validated parameters
• Results are traceable from sample to report

7) Stay within your regulatory framework

Requirements vary by region:

• US: FDA clearance/approval, CLIA lab requirements, and possibly state rules
• EU/UK: IVDR/UKCA requirements, local lab accreditation standards
• Other regions: national medical device and laboratory regulations

8) If you make changes, assess regulatory impact

Changes that can affect clearance include:

• New specimen type
• New target/variant
• New extraction method
• Different instrument
• New software version
• Changed interpretation rules
• Different cutoffs or reporting claims

Any such change should be reviewed by regulatory/quality personnel before implementation.

9) Keep documentation ready for inspection

Maintain:

• Device certificates and IFU
• Validation/verification reports
• Training records
• QC and maintenance logs
• Change control records
• Risk assessments
• Complaints and adverse event handling records

10) Consult your regulatory and quality experts early

If you’re developing or modifying a workflow, work with:

• Regulatory affairs
• Quality assurance
• Clinical/medical director
• Manufacturer support

They can determine whether your intended use remains within clearance or needs a new submission.

If you want, I can also give you a step-by-step compliance SOP template for qPCR IVD workflows or a gap assessment checklist for FDA/IVDR.